• Thu, December 14, 2023
Subbu Nambi Initiated (AKYA) at Hold on, Dec 14th, 2023
Subbu Nambi of Guggenheim, Initiated "Akoya Biosciences, Inc." (AKYA) at Hold on, Dec 14th, 2023.
Subbu has made no other calls on AKYA in the last 4 months.
There are 4 other peers that have a rating on AKYA. Out of the 4 peers that are also analyzing AKYA, 0 agree with Subbu's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Subbu
- David Westenberg of "Piper Sandler" Maintained at Buy with Decreased Target to $8 on, Monday, November 13th, 2023
- Mason Carrico of "Stephens & Co." Maintained at Buy with Decreased Target to $9 on, Monday, November 13th, 2023
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $8 on, Tuesday, October 24th, 2023
- John Sourbeer of "UBS" Maintained at Strong Buy with Decreased Target to $7 on, Thursday, October 12th, 2023
